GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Aodong Pharmaceutical Group Co Ltd (SZSE:000623) » Definitions » Total Equity

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Total Equity : ¥28,799 Mil (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Jilin Aodong Pharmaceutical Group Co Total Equity?

Jilin Aodong Pharmaceutical Group Co's total equity for the quarter that ended in Mar. 2024 was ¥28,799 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Jilin Aodong Pharmaceutical Group Co Total Equity Historical Data

The historical data trend for Jilin Aodong Pharmaceutical Group Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jilin Aodong Pharmaceutical Group Co Total Equity Chart

Jilin Aodong Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22,444.70 23,529.28 25,038.75 26,337.59 27,499.61

Jilin Aodong Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26,849.90 27,205.44 27,338.11 27,499.61 28,798.93

Jilin Aodong Pharmaceutical Group Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Jilin Aodong Pharmaceutical Group Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=32266.141-4766.529
=27,500

Jilin Aodong Pharmaceutical Group Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=32560.327-3761.401
=28,799

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jilin Aodong Pharmaceutical Group Co Total Equity Related Terms

Thank you for viewing the detailed overview of Jilin Aodong Pharmaceutical Group Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Business Description

Traded in Other Exchanges
N/A
Address
No. 2158, Jidong Street, Dunhua, CHN, 133700
Jilin Aodong Pharmaceutical Group Co Ltd is engaged in manufacturing of pharmaceuticals. Its products include Anshen Bunao Liquid, Antelope Cough Syrup, Yangxue Yin Oral Liquid, Xinnao Shutong Capsule, Calf Spleen Extract Injection, Xuefu Zhuyu Oral Liquid, and others.
Executives
Guo Shu Qin Directors, executives
Wang Zhen Yu Directors, Directors, and Executives
Zhao Da Long Director
Yang Kai Directors, executives
Li Xiu Lin Director
Zhang Shu Yuan Directors, executives
Chen Yong Feng Supervisors
Zhang Ming Jing Supervisors
Li An Ning Supervisors
Lin Xiao Lin Executives
Ying Gang Director
Guo Li Supervisors
Xu Dong Lin Supervisors
Zhu Yan Directors, executives
Li Li Ping Supervisors

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Headlines

No Headlines